Table 2.

Adverse Events (AEs) in rectal cancer patients treated with intensive neoadjuvant chemoradiotherapy

AEs	No. of patients (%)
Grade 3-4 toxicity during CRT
Anemia	0(0%)
Leucopenia	2(2.1%)
Thrombocytopenia	4(4.2%)
Diarrhea	6(6.3%)
AEs of surgery
At least one adverse event	18(18.8%)
Anastomotic fistula	2(2.1%)
Pulmonary infection	3(3.1%)
Urinary tract infection	3(3.1%)
Incision infection	11(11.5%)
Intestinal obstruction	3(3.1%)